PeptideStack
5.2kquestions
20kanswers
220users

How many vials from a WXT lot should I send for identity confirmation by mass spectrometry?

Asked 23 Sept 2025Modified 7 months agoViewed 14k times
6

What I am working with: WXT · identity confirmation by mass spectrometry.

I have worked this out and I would like someone to find the error, because I suspect there is one.

My working so far, for the record, is below, and I am fairly sure the error is in the unit conversion rather than the algebra.

Is my approach right even if my number is wrong?

batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
cost-analysis
cost-analysis

Cost arithmetic done honestly: cost per milligram after dead-space loss, list versus net price, comparing a multi-dose vial to a fixed-dose pen,…

261 questions
shareeditfollowflag
SF
askedshear_at_the_front15k2823 Sept 2025
5I have seen exactly this failure mode twice and both times it was the diluent. – grainne_ahearn 7 months ago
6The distinction between purity and content cannot be repeated often enough here. – ilaria_bertone 9 months ago
add a comment

5 Answers

Sorted by votes
66

The practical consequence is that spot-testing one vial from a new supplier is better than assuming they are all the same.

If you have reason to suspect inhomogeneity — different appearance in different vials, or a long or warm shipment — testing more vials is the diagnostic move.

Specifically, if the lot was manufactured in multiple batches, testing vials from each batch separately establishes whether batch-to-batch variation is acceptable.

Lyophilised peptide homogeneity studies show that vial-to-vial variation is usually small but occasionally large, depending on the distribution in the freeze-dryer.

If testing multiple vials, state how many you tested and why you chose those vials.

shareimprove this answerflag
GH
answeredgreta_holzmann15k1816 Nov 2025
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
43

The honest statement is that unless you have tested multiple vials or have segregation data, you are making an assumption about lot homogeneity that may not hold.

Acceptance Sampling by Attributes defines the number of samples you need from a lot to claim a specified quality level at a specified risk — it is in ANSI standard Z1.4.

Stated carefully, if the entire lot failed qualification, a retest on a different vial is sometimes done, but reporting a retest result under the same lot number is misleading.

Sampling plans for pharmaceutical manufacturing are defined in ISO 2859 and ANSI Z1.4, and they are based on statistical sampling theory.

One qualification: testing more vials gives better confidence, but at some point the cost outweighs the benefit.

The practical summary: a lot number without a sampling statement is a lot number without meaning.

shareimprove this answerflag
MI
answeredmicron2236k13827 Nov 2025
34

On the detail: a certificate that reports one test result on one vial extrapolates to claim that all two hundred vials in the lot are identical, which is an assumption worth questioning.

For a quantitative result like content, the acceptable range determines how many vials you need to test to establish the lot complies.

Worth being precise here: the sample size determination requires choosing a confidence level and an acceptable error rate, and the smaller the error rate you want, the larger your sample must be.

Published data on lot homogeneity from manufacturers who sample multiple vials consistently find variation below the published specifications, suggesting the sampling plans work.

Assume segregation is possible, and design your sampling to catch it if it exists.

edited 24 Dec 2025 by Dr_Fatima_Belkacem — added a caveat about sampling

shareimprove this answerflag
DB
answeredDr_Fatima_Belkacem52k1389 Dec 2025
27

Concretely, if a lot has visibly segregated — some vials showing different appearance — then sampling the top and bottom of the shipment is worth doing.

Under AQL sampling plans, testing two vials from a fifty-vial lot gives you an operating characteristic curve that tells you what risks you are accepting.

Lyophilised peptide homogeneity studies show that vial-to-vial variation is usually small but occasionally large, depending on the distribution in the freeze-dryer.

I would treat a "complies with" statement without sampling details as a claim rather than as evidence.

If testing multiple vials, state how many you tested and why you chose those vials.

shareimprove this answerflag
TM
answeredtobias_maartens94k25820 Dec 2025
3Note that the label instructions differ between agents on precisely this point. – j_wierzbicki 8 months ago
add a comment
15

Stated carefully, the single most misleading statement on a research-grade certificate is a lot number with no statement of how many vials from that lot were tested.

Published segregation failures show that even modern automated processes sometimes produce lots with measurable vial-to-vial variation.

Sampling plans for pharmaceutical manufacturing are defined in ISO 2859 and ANSI Z1.4, and they are based on statistical sampling theory.

The caveat is that sampling is a trade-off between cost and confidence, and neither test nor assumption is cost-free.

The practical summary: a lot number without a sampling statement is a lot number without meaning.

shareimprove this answerflag
VI
answeredvialroom87k14831 Dec 2025
I would add a sentence about sterility here, since it is the thing people skip. – bea_castellanos 11 days ago
The placebo-arm figure is the part everyone omits. – Dr_Rosalind_Achebe 2 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.